• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Guideline for management of the clinical T1 renal mass.

作者信息

Campbell Steven C, Novick Andrew C, Belldegrun Arie, Blute Michael L, Chow George K, Derweesh Ithaar H, Faraday Martha M, Kaouk Jihad H, Leveillee Raymond J, Matin Surena F, Russo Paul, Uzzo Robert G

机构信息

American Urological Association Education and Research, Inc., Linthicum, Maryland, USA.

出版信息

J Urol. 2009 Oct;182(4):1271-9. doi: 10.1016/j.juro.2009.07.004. Epub 2009 Aug 14.

DOI:10.1016/j.juro.2009.07.004
PMID:19683266
Abstract
摘要

相似文献

1
Guideline for management of the clinical T1 renal mass.临床T1期肾肿块管理指南
J Urol. 2009 Oct;182(4):1271-9. doi: 10.1016/j.juro.2009.07.004. Epub 2009 Aug 14.
2
Kidney cancer: first guidelines for unilateral cT1 renal tumor management.肾癌：单侧cT1肾肿瘤管理的首个指南
Nat Rev Urol. 2010 Mar;7(3):124-5. doi: 10.1038/nrurol.2010.22.
3
Renal cell carcinoma guideline.肾细胞癌指南。
Eur Urol. 2007 Jun;51(6):1502-10. doi: 10.1016/j.eururo.2007.03.035. Epub 2007 Mar 28.
4
A review of the clinical features pathology: investigation and management of renal cell carcinoma.肾细胞癌的临床特征、病理、检查及治疗综述。
East Afr Med J. 1978 Jul;55(7):341-5.
5
Current management of renal cell carcinoma.肾细胞癌的当前管理
CA Cancer J Clin. 1996 Sep-Oct;46(5):284-302. doi: 10.3322/canjclin.46.5.284.
6
Update on staging controversies for locally advanced renal cell carcinoma.局部晚期肾细胞癌分期争议的最新进展。
Expert Rev Anticancer Ther. 2007 Jul;7(7):909-14. doi: 10.1586/14737140.7.7.909.
7
Kidney cancer: current management guidelines.肾癌：当前的管理指南
Hosp Med. 2002 Apr;63(4):214-7. doi: 10.12968/hosp.2002.63.4.2039.
8
[Nephroblastomas: Almost exclusively in clinical trials!].肾母细胞瘤：几乎仅见于临床试验！
Pathologe. 2016 Mar;37(2):166-71. doi: 10.1007/s00292-016-0148-x.
9
[Importance of the macroscopic examination and histologic report in the therapeutic management of kidney tumors].[大体检查和组织学报告在肾肿瘤治疗管理中的重要性]
Ann Pathol. 2009 Nov;29 Spec No 1:S40-4. doi: 10.1016/j.annpat.2009.08.001. Epub 2009 Oct 7.
10
[Problems in the therapy of kidney neoplasms].[肾肿瘤治疗中的问题]
Nihon Hinyokika Gakkai Zasshi. 1985 Nov;76(11):1612-8.

引用本文的文献

1
Narrative Review of Von Hippel-Lindau Syndrome: From Discovery to Modern Medical and Surgical Therapies.冯·希佩尔-林道综合征的叙述性综述：从发现到现代医学与外科治疗
J Kidney Cancer VHL. 2025 Sep 5;12(3):16-24. doi: 10.15586/jkc.v12i3.396. eCollection 2025.
2
Prognostic comparison of partial and radical nephrectomy for T1b renal cell carcinoma with SEER database analysis.基于监测、流行病学和最终结果（SEER）数据库分析的T1b期肾细胞癌行部分肾切除术与根治性肾切除术的预后比较
Sci Rep. 2025 Aug 9;15(1):29163. doi: 10.1038/s41598-025-14493-z.
3
Microwave ablation versus combined microwave ablation and transarterial chemoembolization for T1a renal cell carcinoma: a Single-Center retrospective study.
微波消融与微波消融联合经动脉化疗栓塞治疗T1a期肾细胞癌：一项单中心回顾性研究。
BMC Urol. 2025 Jul 14;25(1):167. doi: 10.1186/s12894-025-01858-9.
4
Predicting hemorrhagic complications in robotic-assisted partial nephrectomy for renal tumors: simplifying risk assessment with tumor diameter and depth.预测机器人辅助肾肿瘤部分肾切除术的出血并发症：通过肿瘤直径和深度简化风险评估
J Robot Surg. 2025 Jul 10;19(1):368. doi: 10.1007/s11701-025-02537-5.
5
Diagnostic performance of the clear cell likelihood score integrated with cystic degeneration or necrosis on MR imaging for identifying clear cell renal cell carcinoma in cT1 solid renal masses.在磁共振成像（MR）上，结合囊性退变或坏死的透明细胞可能性评分对cT1期实性肾肿块中透明细胞肾细胞癌的诊断效能。
Insights Imaging. 2025 Jul 3;16(1):149. doi: 10.1186/s13244-025-02029-y.
6
Technique and Outcomes of Radiofrequency Ablation of Biopsy-Proven 3-4 cm T1a Renal Cell Carcinoma.经活检证实的3 - 4厘米T1a期肾细胞癌的射频消融技术及结果
Biomedicines. 2025 May 24;13(6):1296. doi: 10.3390/biomedicines13061296.
7
Robotic partial nephrectomy to treat large (T2) cystic renal cell carcinoma: a multi-institutional analysis (ROSULA Collaborative Group).机器人辅助部分肾切除术治疗大型（T2期）囊性肾细胞癌：一项多机构分析（ROSULA协作组）
Int Urol Nephrol. 2025 Jun 21. doi: 10.1007/s11255-025-04604-0.
8
Perioperative, Functional, and Oncological Outcomes of Robotic-Assisted Partial Nephrectomy in 1,267 Indian Patients: A Multicenter Analysis by the Indian Robotic Partial Nephrectomy (IRPN) Collaborative Group.1267例印度患者机器人辅助部分肾切除术的围手术期、功能及肿瘤学结局：印度机器人部分肾切除术（IRPN）协作组的多中心分析
Cureus. 2025 May 16;17(5):e84209. doi: 10.7759/cureus.84209. eCollection 2025 May.
9
Efficacy and safety of self-retaining double-needle barb suture in transabdominal path robot-assisted laparoscopic partial nephrectomy for T1 renal cancer.自固定双针倒刺缝线在经腹途径机器人辅助腹腔镜下T1期肾癌部分肾切除术中的疗效及安全性
BMC Cancer. 2025 Mar 10;25(1):429. doi: 10.1186/s12885-025-13825-6.
10
Artificial intelligence links CT images to pathologic features and survival outcomes of renal masses.人工智能将CT图像与肾肿块的病理特征及生存结果相关联。
Nat Commun. 2025 Feb 7;16(1):1425. doi: 10.1038/s41467-025-56784-z.